UK Public “Experiment” With OTC Zocor Challenged In Lancet Editorial
This article was originally published in The Tan Sheet
Executive Summary
Editors of the UK medical journal The Lancet suggest that a surveillance system be put in place to monitor use of OTC simvastatin in an editorial appearing in the journal's May 22 issue
You may also be interested in...
OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter
An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet
OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter
An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet
OTC Simvastatin In UK Will Provide Boon For Rx Counterparts – Lancet Letter
An Rx-to-OTC switch of 10 mg simvastatin is "not guaranteed" to take pressure off government health expenditures in the UK, according to a letter to the editor in the July 31 Lancet